Tod Pál, Farkas Nelli, Németh Dávid, Szénási Gábor, Vincze Áron, Hágendorn Roland, Czakó László, Illés Dóra, Izbéki Ferenc, Dunás-Varga Veronika, Papp Mária, Hamvas József, Varga Márta, Gombos Katalin, Nagy Tamás, Márton Zsolt, Faluhelyi Nándor, Török Imola, Ince Ali Tüzün, Galeev Shamil, Hegyi Péter Jenő, Szentesi Andrea, Párniczky Andrea, Szakács Zsolt, Hegyi Péter, Hamar Péter
Szentágothai Research Centre, Medical School, Institute for Translational Medicine, University of Pécs, Pécs, Hungary.
School of Medicine, Institute of Translational Medicine, Semmelweis University, Budapest, Hungary.
Front Med (Lausanne). 2021 Aug 18;8:671917. doi: 10.3389/fmed.2021.671917. eCollection 2021.
Acute pancreatitis (AP) is a life-threatening disease. We aimed to explore the prognostic relevance of renal function based on estimated glomerular filtration rate (eGFR). A prospective registry of AP patients was established by the Hungarian Pancreatic Study Group. Data of 1,224 consecutive patients were collected between 2012 and 2017. Patients were divided into 3 groups according to their eGFR measured within 24 h of hospitalization: renal function: >90 mL/min, to moderate renal functional : 30-90 mL/min and renal : <30 mL/min. Associations of eGFR with outcome (survival, length of hospitalization, AP severity, blood glucose), inflammatory markers (erythrocyte sedimentation rate, white blood cell count), anemia and organ failure (heart, kidney, liver) were analyzed. Death, longer hospitalization and severe AP, but not the cause of AP, were significantly associated with lower eGFR. The inflammatory markers (CRP, WBC count) but not anemia (Hb, Htk) were closely associated with severe renal dysfunction. Renal function was associated with heart and renal failure but not with other complications of AP such as respiratory failure, local pancreatic complications, diabetes or peptic ulcer. eGFR was not associated with liver damage (ALAT, γ-GT) or liver function (serum bilirubin) although biliary complications, alcohol and metabolic syndrome were the most common etiologies of AP. Our study suggests a useful prognostic value of eGFR in AP patients. Even mild eGFR reduction predicted mortality, severity of AP and the length of hospitalization. Thus, precise evaluation of renal function should be considered for assessing AP severity and outcome.
急性胰腺炎(AP)是一种危及生命的疾病。我们旨在探讨基于估计肾小球滤过率(eGFR)的肾功能与预后的相关性。匈牙利胰腺研究小组建立了一个AP患者的前瞻性登记系统。在2012年至2017年期间收集了1224例连续患者的数据。根据住院24小时内测得的eGFR将患者分为3组:肾功能:>90 mL/分钟、中度肾功能:30 - 90 mL/分钟和肾功能:<30 mL/分钟。分析了eGFR与结局(生存率、住院时间、AP严重程度、血糖)、炎症标志物(红细胞沉降率、白细胞计数)、贫血和器官衰竭(心脏、肾脏、肝脏)之间的关联。死亡、更长的住院时间和严重的AP,但不是AP的病因,与较低的eGFR显著相关。炎症标志物(CRP、白细胞计数)而非贫血(血红蛋白、血细胞比容)与严重肾功能不全密切相关。肾功能与心脏和肾衰竭相关,但与AP的其他并发症如呼吸衰竭、胰腺局部并发症、糖尿病或消化性溃疡无关。尽管胆源性并发症、酒精和代谢综合征是AP最常见的病因,但eGFR与肝损伤(谷丙转氨酶、γ-谷氨酰转移酶)或肝功能(血清胆红素)无关。我们的研究表明eGFR在AP患者中有有用的预后价值。即使是轻度的eGFR降低也可预测死亡率、AP的严重程度和住院时间。因此,在评估AP的严重程度和结局时应考虑对肾功能进行精确评估。